Bank of America Corp DE decreased its stake in shares of Humana Inc (NYSE:HUM) by 2.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,300,941 shares of the insurance provider’s stock after selling 47,221 shares during the period. Bank of America Corp DE’s holdings in Humana were worth $659,173,000 as of its most recent SEC filing.
A number of other institutional investors also recently added to or reduced their stakes in HUM. FMR LLC grew its stake in shares of Humana by 1.4% in the 3rd quarter. FMR LLC now owns 12,379,797 shares of the insurance provider’s stock worth $4,190,809,000 after purchasing an additional 167,283 shares during the last quarter. BlackRock Inc. grew its stake in shares of Humana by 1.2% in the 3rd quarter. BlackRock Inc. now owns 12,311,736 shares of the insurance provider’s stock worth $4,167,767,000 after purchasing an additional 140,731 shares during the last quarter. Vanguard Group Inc grew its stake in shares of Humana by 1.4% in the 3rd quarter. Vanguard Group Inc now owns 10,104,225 shares of the insurance provider’s stock worth $3,420,482,000 after purchasing an additional 140,864 shares during the last quarter. Capital International Investors grew its stake in shares of Humana by 3,030.3% in the 3rd quarter. Capital International Investors now owns 8,217,296 shares of the insurance provider’s stock worth $2,781,719,000 after purchasing an additional 7,954,786 shares during the last quarter. Finally, Renaissance Technologies LLC grew its stake in shares of Humana by 14.1% in the 3rd quarter. Renaissance Technologies LLC now owns 3,174,800 shares of the insurance provider’s stock worth $1,074,733,000 after purchasing an additional 391,300 shares during the last quarter. 93.57% of the stock is currently owned by hedge funds and other institutional investors.
Shares of HUM opened at $282.17 on Tuesday. Humana Inc has a one year low of $261.35 and a one year high of $355.88. The stock has a market capitalization of $38.00 billion, a price-to-earnings ratio of 19.39, a PEG ratio of 1.13 and a beta of 0.94. The company has a quick ratio of 1.68, a current ratio of 1.68 and a debt-to-equity ratio of 0.43.
The business also recently declared a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Friday, March 29th will be issued a dividend of $0.55 per share. This is a boost from Humana’s previous quarterly dividend of $0.50. This represents a $2.20 annualized dividend and a dividend yield of 0.78%. The ex-dividend date of this dividend is Thursday, March 28th. Humana’s dividend payout ratio (DPR) is currently 6.87%.
Several equities analysts have recently issued reports on HUM shares. Zacks Investment Research raised shares of Humana from a “hold” rating to a “buy” rating and set a $327.00 price objective on the stock in a research note on Thursday, December 20th. Barclays reaffirmed a “buy” rating and issued a $351.00 price objective on shares of Humana in a research note on Sunday, January 6th. Citigroup decreased their target price on shares of Humana from $397.00 to $362.00 and set a “buy” rating for the company in a report on Thursday, February 7th. ValuEngine cut shares of Humana from a “buy” rating to a “hold” rating in a report on Friday, December 7th. Finally, Cantor Fitzgerald reiterated a “hold” rating and issued a $325.00 target price on shares of Humana in a report on Wednesday, January 2nd. Five investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. Humana has an average rating of “Buy” and an average target price of $355.06.
In related news, insider Christopher H. Hunter sold 15,586 shares of the firm’s stock in a transaction that occurred on Monday, February 25th. The shares were sold at an average price of $305.24, for a total transaction of $4,757,470.64. Following the completion of the sale, the insider now directly owns 28,100 shares in the company, valued at $8,577,244. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Roy A. Beveridge sold 8,278 shares of the firm’s stock in a transaction that occurred on Tuesday, February 19th. The stock was sold at an average price of $307.16, for a total transaction of $2,542,670.48. Following the sale, the insider now owns 12,409 shares of the company’s stock, valued at $3,811,548.44. The disclosure for this sale can be found here. Company insiders own 0.54% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This article was first published by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright law. The original version of this article can be read at https://sportsperspectives.com/2019/03/19/humana-inc-hum-shares-sold-by-bank-of-america-corp-de.html.
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Article: Google Finance Portfolio
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.